PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection
Science · 06.10.2023 · 382 (6666)
DOI: 10.1126/science.adg2253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 06.10.2023. Verfasst von Daniel Fisch und 18 weiteren Autor:innen. Beteiligte Einrichtung: Host-Toxoplasma Interaction Laboratory, The Francis Crick Institute, London, UK. Hauptthemen laut MEDLINE: GTP-Binding Proteins, Immunity, Innate, Interferon-gamma, Proto-Oncogene Proteins c-pim-1. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cancer Research UK, Wellcome Trust, Medical Research Council.
Abstract (Originalsprache)
Disruption of cellular activities by pathogen virulence factors can trigger innate immune responses. Interferon-γ (IFN-γ)–inducible antimicrobial factors, such as the guanylate binding proteins (GBPs), promote cell-intrinsic defense by attacking intracellular pathogens and by inducing programmed cell death. Working in human macrophages, we discovered that GBP1 expression in the absence of IFN-γ killed the cells and induced Golgi fragmentation. IFN-γ exposure improved macrophage survival through the activity of the kinase PIM1. PIM1 phosphorylated GBP1, leading to its sequestration by 14-3-3σ, which thereby prevented GBP1 membrane association. During Toxoplasma gondii infection, the virulence protein TgIST interfered with IFN-γ signaling and depleted PIM1, thereby increasing GBP1 activity. Although infected cells can restrain pathogens in a GBP1-dependent manner, this mechanism can protect uninfected bystander cells. Thus, PIM1 can provide a bait for pathogen virulence factors, guarding the integrity of IFN-γ signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Host-Toxoplasma Interaction Laboratory, The Francis Crick Institute, London, UK.
- Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, UK.
- European Molecular Biology Laboratory, 71 Avenue des Martyrs, Grenoble, France.
- Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, UK.
- Department of Health Sciences and Technology (D-HEST), ETH Zürich, Institute of Translational Medicine (ITM), Zürich, Switzerland.
- Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.
ORCID-Profile: Daniel Fisch, Moritz M Pfleiderer, Eleni Anastasakou, Gillian M Mackie, Fabian Wendt, Barbara Clough, Samuel Lara-Reyna, Ambrosius P Snijders, Masahiro Yamamoto, Andrew D Beggs, Avinash R Shenoy, Bernd Wollscheid, Kendle M Maslowski, Wojtek P Galej, Eva-Maria Frickel
Förderung
- Cancer Research UK
- Wellcome Trust
- Medical Research Council
Zitieren
APA
Fisch, D., Pfleiderer, M. M., Anastasakou, E., Mackie, G. M., Wendt, F., Liu, X., Clough, B., Lara-Reyna, S., Encheva, V., Snijders, A. P., Bando, H., Yamamoto, M., Beggs, A. D., Mercer, J., Shenoy, A. R., Wollscheid, B., Maslowski, K. M., Galej, W. P., & Frickel, E. M. (2023). PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection. Science, 382(6666). https://doi.org/10.1126/science.adg2253
Vancouver
Fisch D, Pfleiderer MM, Anastasakou E, Mackie GM, Wendt F, Liu X, et al. PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection. Science. 2023;382(6666). doi:10.1126/science.adg2253
BibTeX
@article{Fisch2023,
author = {Fisch, Daniel and Pfleiderer, Moritz M and Anastasakou, Eleni and Mackie, Gillian M and Wendt, Fabian and Liu, Xiangyang and Clough, Barbara and Lara-Reyna, Samuel and Encheva, Vesela and Snijders, Ambrosius P and Bando, Hironori and Yamamoto, Masahiro and Beggs, Andrew D and Mercer, Jason and Shenoy, Avinash R and Wollscheid, Bernd and Maslowski, Kendle M and Galej, Wojtek P and Frickel, Eva-Maria},
title = {PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection},
journal = {Science},
year = {2023},
volume = {382},
number = {6666},
doi = {10.1126/science.adg2253}
}
EUVIMED